Taro Pharmaceutical Industries Ltd (NYSE:TARO)
| 37.77 Delayed Data As of Sep 26 |  -0.01 / -0.03%Today’s Change | 22.89 Today|||52-Week Range 42.22 | +30.06% Year-to-Date |
Latest TARO News | Press Releases
No recent news for Taro Pharmaceutical Industries Ltd.
Today’s Trading
| Previous close | 37.78 |
| Today’s open | 37.64 |
| Day’s range | 37.64 - 38.00 |
| Volume | 22,218 |
| Average volume (3 months) | 57,880 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -56.26% |
| Earnings growth (this year) | +86.76% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +2.07% |
| P/E ratio | 65.1 |
| Price/Sales | 1.60 |
| Price/Book | 0.82 |
Competitors
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | November 6, 2023 |
| EPS forecast (this quarter) | $0.30 |
| Annual revenue (last year) | $573.0M |
| Annual profit (last year) | $25.4M |
| Net profit margin | 4.44% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Haifa Bay, Haifa |
Forecasts
